Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från CombiGene via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-05-17 11:00:00
On Monday May 16, 2022, CEO Jan Nilsson presented at Aktiedagen in Göteborg. In his presentation, Jan talks about the company's two projects, the epilepsy project CG01, which is being developed together with Spark Therapeutics, and the lipodystrophy project CGT2. Jan also addresses CombiGene's business development and ambitions to find additional gene therapy projects with high potential for value creation within CombiGene. (Please observe that the presentation is held in Swedish.)
Information
Link: https://www.youtube.com/watch?v=BDvmFdrOMsc